Hollywood Mark
EVP & Chief Operating Officer
Hollywood Mark has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 6, 2026.
On the most recent filing, Hollywood Mark is listed as EVP & Chief Operating Officer at Zymeworks Inc. Inside the rolling window, Hollywood Mark reported no open-market purchases and 1 open-market sale totaling $139K in ZYME.
Companies traded
Other insiders at ZYME
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$139K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hollywood Mark made?
Hollywood Mark has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Hollywood Mark trade?
Hollywood Mark has filed SEC Form 4 disclosures for 1 company, including ZYME.
When was Hollywood Mark's most recent SEC Form 4 filing?
Hollywood Mark's most recent SEC Form 4 filing on Tracefour is dated Jul 6, 2026.
What is Hollywood Mark's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hollywood Mark is listed as EVP & Chief Operating Officer.
What is Hollywood Mark's total buy and sell value in the current window?
Inside the rolling retention window, Hollywood Mark bought $0 and sold $139K based on SEC Form 4 filings.
What was Hollywood Mark's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,120 ZYME shares on 2026-01-12, worth $139K, per SEC Form 4 filings.